Ticker
KALVCompany Name
KALVISTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Tangible Assets |
---|---|---|---|
6/30/2025 | $ 215.5M | $ 0 | $ 215.5M |
3/31/2025 | $ 250.77M | $ 0 | $ 250.77M |
12/31/2024 | $ 275.99M | $ 0 | $ 275.99M |
9/30/2024 | $ 160.83M | $ 0 | $ 160.83M |
6/30/2024 | $ 200.2M | $ 0 | $ 200.2M |
3/31/2024 | $ 235.4M | $ 0 | $ 235.4M |
12/31/2023 | $ 113.97M | $ 0 | $ 113.97M |
9/30/2023 | $ 138.74M | $ 0 | $ 138.74M |
6/30/2023 | $ 160.33M | $ 0 | $ 160.33M |
3/31/2023 | $ 183.2M | $ 0 | $ 183.2M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles
(=) Tangible Assets
Tangible Assets for KALVISTA PHARMACEUTICALS INC is calculated as follows: Assets [ $ 75.45M ] - Intangibles [ $ 0 ]
(=) Tangible Assets [ $ 75.45M ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.47K |
---|---|
min | $ 0 |
max | $ 5.31B |
average | $ 996.29M |
median | $ 389.26M |
std | $ 1.28B |